In 1982, it was suggested that hepatic Tau could play a protective role in hepatocytes against hepatotoxicants such as CCl4, and that dietary Tau may be a useful treatment in hepatotoxin-induced liver injury [228]. This evidence concerns the gene MAPT and injury.